Smith & Nephew share price reaches artificial high
This article was originally published in Clinica
Smith & Nephew will have to live with a grossly inflated figure as its year-high for the next 12 months after apparent extreme volatility in its share price over a two-day period. The price distortion was attributed to a new closing auction system operated by the London Stock Exchange, combined with a single transaction.
You may also be interested in...
3D-printing company Carbon and in vitro diagnostics maker Resolution Medical announced plans to manufacture more than one million 3D-printed nasal swabs per week to test for COVID-19. See what Resolution Medical’s president Shawn Patterson said about it here.
FDA warning to "Genesis II Church of Health and Healing " wasn't its first to the organization about promoting a chlorine dioxide formulation, "Miracle Mineral Solution," as an unapproved new drug. 'Infowars' host Alex Jones also was warned about bogus COVID-19 claims.
The first major revision since 2007 notably provides a legal foundation for special approvals under a public health crisis.